Video

As cross-border restructurings become increasingly common, understanding how different jurisdictions approach restructuring plans is essential for practitioners advising multinational clients. This panel will examine and compare key features of restructuring frameworks in the U.S., U.K., Canada and the Netherlands, highlighting similarities, differences, and recent developments shaping international practice.

The intersection between insolvency and arbitration remains one of the most complex and unsettled areas of cross-border dispute resolution. This panel will examine the ongoing debate within UNCITRAL Working Group V on determining which law governs the effect of insolvency proceedings on arbitration agreements and arbitral proceedings, and how different jurisdictions approach this question in practice.

The U.K. Scheme of Arrangement and other international restructuring tools have attracted global attention for their flexibility and effectiveness. This panel will explore whether the U.S. should adopt a similar framework, and will analyze potential benefits, challenges and implications for debtors and creditors within the existing chapter 11 system.

This panel will provide a comprehensive overview of recent developments affecting cross-border insolvency practice. The panelists will include updates on third-party releases and the Credito Real appeal by the U.S. Trustee, recent trends in asset-tracing across offshore jurisdictions, and emerging issues in the Caribbean and Canada, including evolving director duties and disqualification regimes.

Hosted by ABI's Real Estate CommitteeThe office sector remains one of the most challenged areas of commercial real estate, with fundamentals shifting in ways that continue to test owners, lenders and tenants alike. While prime properties in select markets are benefiting from a clear flight to quality, overall leasing activity is uneven, and vacancy rates remain elevated nationwide. With billions of dollars of office-based loans in distress and higher rates with tighter underwriting colliding with declining property valuations, the office asset class continues to be a real estate sector that restructuring professionals should watch closely.The Real Estate Committee is pleased to provide a deep dive into this market from the perspective of a national bank special assets manager, a CMBS attorney and a transaction professional through a hybrid Zoom webinar and in-person program at the New York City offices of Pillsbury.

ABI’s Health Care Program is a one-of-a-kind annual conference focusing on the future of health care and the latest on restructurings in this critical industry. The 2025 program returned to its roots in Washington, D.C., Oct. 22-23, and explored several key insolvency issues that are dominating the health care sphere — as well as those that are likely to arise in the coming years. We are grateful for the support and continued partnership of the program's Founding Sponsors, Greenberg Traurig, LLP and SAK Healthcare LLC. The following recorded sessions are available for purchase individually or as an economical bundle.

In recent years, the life sciences sector has faced mounting pressures from capital market volatility, regulatory scrutiny and evolving patient data standards. With a noticeable uptick in financial distress and a decline in successful bankruptcy resolutions, stakeholders are grappling with existential questions about sustainability, compliance, and trust. Bringing together finance, legal, operational and regulatory perspectives, this session will provide attendees with practical insights into how companies can manage risk, preserve value and protect trust – even under duress.

This panel will examine key regulatory developments affecting the health care sector, including recent policy changes, enforcement trends, compliance challenges and stakeholder decision-making, as well as how shifting regulations are influencing restructuring strategies and creditor recoveries.

This keynote will discuss how a health care futures market could help stabilize costs for payers and providers, and will explore various financial tools and incentives that could help make health care more predictable and investable. This in-depth talk also will examine the convergence of biology and technology into investable frontiers in medicine — and steps that practitioners can take now to preserve innovation while helping to fix broken balance sheets.